| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/04/2008 | CA2679400A1 Combination therapy for treatment of immune disorders |
| 09/04/2008 | CA2679374A1 Method for treating or preventing systemic inflammation |
| 09/04/2008 | CA2679315A1 Method for alleviating side effects of retinoic acid therapy and/or improving efficacy without interfering with efficacy |
| 09/04/2008 | CA2679312A1 Co-crystals and pharmaceutical compositions comprising the same |
| 09/04/2008 | CA2679300A1 Amino acid composition |
| 09/04/2008 | CA2679263A1 Sulfonamide compound |
| 09/04/2008 | CA2679257A1 Compounds for preventing or treating viral infections and methods of use thereof |
| 09/04/2008 | CA2679224A1 Novel compounds |
| 09/04/2008 | CA2679185A1 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 09/04/2008 | CA2679175A1 Indole and indoline cyclopropyl amide derivatives as ep4 receptor antagonists |
| 09/04/2008 | CA2679126A1 Macrocyclic compound |
| 09/04/2008 | CA2678746A1 Composition useful for the treatment of type 2 diabetes |
| 09/04/2008 | CA2678735A1 Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 09/04/2008 | CA2678733A1 Topical composition comprising fluocinolone acetonide for use in depigmentation of the skin |
| 09/04/2008 | CA2678587A1 O-desulfated heparins treating acute exacerbations of chronic obstructive pulmonary disease |
| 09/04/2008 | CA2678582A1 Improvements in and relating to medicinal compositions |
| 09/04/2008 | CA2678577A1 Cyclic urea and carbamate inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| 09/04/2008 | CA2678159A1 Ppar-gamma agonists for the induction of cationic antimicrobial peptide expression as immunoprotective stimulants |
| 09/04/2008 | CA2678073A1 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound |
| 09/04/2008 | CA2678043A1 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms |
| 09/04/2008 | CA2678032A1 Bazedoxifene bis-phosphorates |
| 09/04/2008 | CA2677331A1 Substituted benzodiazepinones, benzoxazepinones and benzothiazepinones as sodium channel blockers |
| 09/04/2008 | CA2677046A1 Indenoisoquinolinone analogs and methods of use thereof |
| 09/04/2008 | CA2676956A1 Product containing inactivated probiotic for children or infants |
| 09/04/2008 | CA2676933A1 Novel phosphodiesterase inhibitors |
| 09/04/2008 | CA2673936A1 Pharmaceutical preparation for the alleviation of endometriosis |
| 09/04/2008 | CA2662142A1 Antimicrobial compositions |
| 09/03/2008 | EP1964925A1 Process for production of optically active 4-hydroxy-1,2,3,4 -tetrahydroquinolines |
| 09/03/2008 | EP1964855A1 Mineral absorption enhancer, food and feeding stuff |
| 09/03/2008 | EP1964849A2 Transfection complexes |
| 09/03/2008 | EP1964845A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964844A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964843A1 Process for production of water-soluble azole prodrug |
| 09/03/2008 | EP1964842A1 5H-THIENO [3,4-c]PYRROLE-4, 6-DIONE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR |
| 09/03/2008 | EP1964841A1 Imidazo[1,2-a]azine and their use as pharmaceuticals |
| 09/03/2008 | EP1964840A1 Imidazo[1,2-a]pyridines and their use as pharmaceuticals |
| 09/03/2008 | EP1964839A2 Quinazoline derivatives as kinase inhibitors |
| 09/03/2008 | EP1964837A1 Anti-tumor agent for multiple myeloma |
| 09/03/2008 | EP1964836A2 A process for the preparation of perindopril erbumine in alpha crystalline form |
| 09/03/2008 | EP1964835A1 Derivatives of psammaplin A, a method for their synthesis and their use for the prevention or treatment of cancer |
| 09/03/2008 | EP1964834A1 Sulphonyltryptophanols |
| 09/03/2008 | EP1964575A1 Pharmaceutical comprising ppar agonist |
| 09/03/2008 | EP1964574A1 Method for treatment or prevention of disease associated with functional disorder of regulatory t cell |
| 09/03/2008 | EP1964573A2 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/03/2008 | EP1964572A2 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 09/03/2008 | EP1964569A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections |
| 09/03/2008 | EP1964568A1 Utilization of hypertension/hypercardia-preventing effect of d-allose |
| 09/03/2008 | EP1964567A1 Pharmaceutical preparation for treating migraine |
| 09/03/2008 | EP1964566A1 Preparation with improved bioabsorbability of sapropterin hydrochloride |
| 09/03/2008 | EP1964565A1 3,11b-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation |
| 09/03/2008 | EP1964564A1 Breakthrough Pain Management |
| 09/03/2008 | EP1964563A1 Pharmaceutical compositions containing calcium antagonist substances combined with platelet aggregation inhibiting agents for use in systemic arterial hypertension and for the prevention of ischemic vascular events |
| 09/03/2008 | EP1964562A1 Pharmaceutical compositions containing derivative substances of thiazolidinediones combined with a biguanide for use in type 2 diabetes mellitus |
| 09/03/2008 | EP1964561A1 Inhibitors of IMPDH enzyme |
| 09/03/2008 | EP1964560A1 Use of inhibitors of the degradation of p27 for the treatment of cancer |
| 09/03/2008 | EP1964559A1 Compositions for the prevention and treatment of vascular dementia |
| 09/03/2008 | EP1964558A1 Pharmaceutical compositions containing intestinal lipase inhibiting substances combined with a chromium dinicotinate o-coordinated complex for use in the treatment and control of obesity and overweight |
| 09/03/2008 | EP1964557A1 Process for producing arsenic trioxide formulations and methods for treating acute myelogenous leukemia using arsenic trioxide |
| 09/03/2008 | EP1964556A1 Therapeutic agent or therapeutic method for ischemic stroke |
| 09/03/2008 | EP1964555A1 Pharmaceutical compositions containing substances that inhibit the reuptake of noradrenaline, dopamine and serotonin, which are combined with an amino acid for the treatment of obesity and overweight |
| 09/03/2008 | EP1964554A1 Lipid mixture and use thereof for the preparation of a product that is intended for enteral or oral administration |
| 09/03/2008 | EP1964553A1 Sustained release pharmaceutical composition of tolterodine |
| 09/03/2008 | EP1964552A1 Analgesic composition of topically applied nonsteoridal antiinflammatory drugs and opioids |
| 09/03/2008 | EP1964551A1 Compositions for the prevention and treatment of primary headache and migraine |
| 09/03/2008 | EP1964550A1 Glucocorticoid-nitrooxyderivative compositions |
| 09/03/2008 | EP1964549A1 Orally disintegrating tablet comprising fat-soluble substance |
| 09/03/2008 | EP1964548A1 Pharmaceutical compositions comprising a calcilytic agent |
| 09/03/2008 | EP1963551A1 Markers for memory t cells and uses thereof |
| 09/03/2008 | EP1963517A1 Process for the production of trans-10, cis 12 octadecadienoic acid |
| 09/03/2008 | EP1963509A1 Catecholamine regulated protein |
| 09/03/2008 | EP1963508A2 COMPOSITIONS AND METHODS OF USING siRNA TO KNOCKDOWN GENE EXPRESSION AND TO IMPROVE SOLID ORGAN AND CELL TRANSPLANTATION |
| 09/03/2008 | EP1963507A1 Anti-myosin va sirna and skin depigmentation |
| 09/03/2008 | EP1963506A2 Compositions and methods for increasing production of recombinant gamma-carboxylated proteins |
| 09/03/2008 | EP1963502A2 Combinations and methods of using an immunomodulatory oligodeoxynucleotide |
| 09/03/2008 | EP1963372A2 Anti-mn antibodies and methods of using same |
| 09/03/2008 | EP1963355A2 New cholest-4-en-3-one oxime derivatives, pharmaceutical compositions comprising them, and preparation process |
| 09/03/2008 | EP1963350A1 Biologically active compounds |
| 09/03/2008 | EP1963349A1 Novel loganin analogues and a process for the preparation thereof |
| 09/03/2008 | EP1963345A2 Processes for the preparation of pure zoledronic acid |
| 09/03/2008 | EP1963344A1 Organophosphoric derivatives useful as anti-parasitic agents |
| 09/03/2008 | EP1963342A2 Crystalline forms of 1-benzoyl-4-[2-]4-methoxy-7-(3-methyl-1h-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1h-pyrrolo[2,3-c]pyridin-3-yl[-1,2-dioxoethyl]-piperazine |
| 09/03/2008 | EP1963338A1 New compounds |
| 09/03/2008 | EP1963337A1 New compounds |
| 09/03/2008 | EP1963336A1 New compounds |
| 09/03/2008 | EP1963335A2 Process for the preparation of olanzapine |
| 09/03/2008 | EP1963334A1 Chromone derivatives useful as antagonists of vr1 receptors |
| 09/03/2008 | EP1963333A1 Process for the preparation of porphyrin derivatives as antimicrobial agents by photodynamic therapy (pdt) |
| 09/03/2008 | EP1963332A1 1 h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 09/03/2008 | EP1963331A1 Azepinoindole derivatives as pharmaceutical agents |
| 09/03/2008 | EP1963330A1 Dimers and adducts of 6-[substituted) phenyl] triazolopyrimidines useful as anticancer agents |
| 09/03/2008 | EP1963329A2 Inhibitors of c-met and uses thereof |
| 09/03/2008 | EP1963328A2 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 09/03/2008 | EP1963327A1 3-(SUBSTITUTED AMINO)-PYRAZOLO[3,4-d]PYRIMIDINES AS EPHB AND VEGFR2 KINASE INHIBITORS |
| 09/03/2008 | EP1963326A1 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors |
| 09/03/2008 | EP1963325A2 Xanthine derivatives, processes for preparing them and their uses |
| 09/03/2008 | EP1963324A1 Heterocyclic compounds, their preparation and their use as antibacterials |
| 09/03/2008 | EP1963323A1 Novel diazabicyclic aryl derivatives and their medical use |
| 09/03/2008 | EP1963322A1 Bicyclic heteroyclic compounds as antiinflammatory agents |
| 09/03/2008 | EP1963321A2 Dibenzonaphthyridine derivatives and methods of use thereof |
| 09/03/2008 | EP1963320A1 Pyrrolopyridine kinase inhibiting compounds |